2164-5515
No
HUM VACC IMMUNOTHER
0
350
UNITED STATES
http://www.tandfonline.com/loi/khvi20
一般,3-6周審稿時(shí)間
容易平均錄用比例
2.592影響因子
生物工程與應(yīng)用微生物小學(xué)科
月期刊平臺(tái)服務(wù)過(guò)的文章錄用時(shí)間為1-3個(gè)月,依據(jù)20年經(jīng)驗(yàn),經(jīng)月期刊專家預(yù)審?fù)ㄟ^(guò)后的文章,投稿通過(guò)率100%以上!
目標(biāo)和范圍:《人類疫苗與免疫療法》是唯一一本專注于人類疫苗和免疫療法的同行評(píng)審期刊?!度A爾街日?qǐng)?bào)》每年出版12期,主要以原創(chuàng)研究文章和評(píng)論的形式出版,并以評(píng)論和新聞更新為特色。還包括關(guān)于一個(gè)引起高度興趣的重點(diǎn)主題的文章和評(píng)論的專題,以及完全致力于這一主題或著名國(guó)際會(huì)議文章的專題。該期刊擁有廣泛而杰出的國(guó)際編輯委員會(huì)成員和副編輯委員會(huì)。該雜志從提交到接受再到出版的周轉(zhuǎn)時(shí)間相對(duì)較快。人類疫苗與免疫療法(HV&I)為展示和討論疫苗學(xué)和免疫療法的前沿研究和發(fā)展提供了一個(gè)平臺(tái)。我們的雜志匯集了在以下領(lǐng)域工作的科學(xué)家、醫(yī)生、公共衛(wèi)生從業(yè)者和分析人員:研究和開(kāi)發(fā)新的疫苗和免疫療法實(shí)驗(yàn)疫苗和免疫治療的新方法用于治療非傳染性疾病,如癌癥的疫苗和免疫療法臨床前研究和臨床試驗(yàn)許可產(chǎn)品及其在該領(lǐng)域的使用許可疫苗和免疫療法對(duì)疾病的影響許可疫苗的安全性和認(rèn)知發(fā)展中國(guó)家的預(yù)防和治療流行病學(xué)和廣泛HV&I提供多種格式,包括原始研究文章、簡(jiǎn)短報(bào)告、案例報(bào)告、評(píng)論和評(píng)論。
Aims & Scope: Human Vaccines & Immunotherapeutics is the only peer-reviewed journal focused on vaccines and immunotherapeutics for humans. The journal publishes 12 issues per year, mostly as original research articles and reviews, and also features commentaries and news updates. Also included are Special Features of articles and reviews on a focused theme of high interest as well as Special Issues devoted entirely to one such topic or to articles from prestigious international conferences.The journal is fully indexed with a broad and distinguished international panel of Editorial Board members and Associate Editors Editorial Board. The journal enjoys relatively rapid turnaround time from submission to acceptance to publication.Human Vaccines & Immunotherapeutics (HV&I) provides a platform for presenting and discussing cutting-edge research and developments in vaccinology and immunotherapy. Our journal brings together scientists, physicians, public health practitioners, and analysts working in the areas of: research and development of novel vaccines and immunotherapeutics experimental vaccines and novel approaches in vaccination and immunotherapy vaccines and immunotherapeutics for treating non-infectious diseases, e.g., cancer preclinical studies and clinical trials licensed products and their use in the field impact of licensed vaccines and Immunotherapeutics on disease safety and perceptions of licensed vaccines prevention and treatment in the developing world epidemiology and pharmaco-economicsHV&I offers a variety of formats including Original Research articles, Short Reports, Case Reports, Reviews, and Commentaries.
快速預(yù)審、投刊前指導(dǎo)、專業(yè)學(xué)術(shù)評(píng)審,對(duì)文章進(jìn)行評(píng)價(jià);
立即咨詢校對(duì)編輯、深度潤(rùn)色,讓稿件符合學(xué)術(shù)規(guī)范,格式體例等標(biāo)準(zhǔn);
立即咨詢適用于語(yǔ)句和結(jié)構(gòu)尚需完善和調(diào)整的中文文章,確保稿件達(dá)到要求;
立即咨詢數(shù)據(jù)庫(kù)包括:期刊、文章、書(shū)籍、會(huì)議、預(yù)印書(shū)、百科全書(shū)和摘要等;
立即咨詢讓作者在期刊選擇時(shí)避免走彎路,縮短稿件被接收的周期;
立即咨詢根據(jù)目標(biāo)期刊格式要求對(duì)作者文章進(jìn)行全面的格式修改和調(diào)整;
立即咨詢幫助作者將稿件提交至目標(biāo)期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢按照您提供的稿件內(nèi)容,指導(dǎo)完成投稿附信(cover letter);
立即咨詢大類學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 | 大類學(xué)科 | 小類學(xué)科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
BIOMARKERS | 醫(yī)學(xué) | 生物工程與應(yīng)用微生物 | 1.73 | 4區(qū) | 1354-750X |
BIOPHARM INTERNATIONAL | 醫(yī)學(xué) | 生物工程與應(yīng)用微生物 | 0.263 | N/A | 1542-166X |
CANCER GENE THERAPY | 醫(yī)學(xué) | 生物工程與應(yīng)用微生物 | 4.681 | N/A | 0929-1903 |
ENERGY EDUC SCI TECH | 醫(yī)學(xué) | 生物工程與應(yīng)用微生物 | N/A | 2區(qū) | 1465-3249 |
DISEASE MARKERS | 醫(yī)學(xué) | 生物工程與應(yīng)用微生物 | 2.761 | 3區(qū) | 0278-0240 |
EXPERT OPINION ON BIOLOGICAL THERAPY | 醫(yī)學(xué) | 生物工程與應(yīng)用微生物 | 3.585 | 3區(qū) | 1471-2598 |
GENETIC COUNSELING | 醫(yī)學(xué) | 生物工程與應(yīng)用微生物 | N/A | N/A | 1015-8146 |
HUMAN GENE THERAPY | 醫(yī)學(xué) | 生物工程與應(yīng)用微生物 | 3.855 | 2區(qū) | 1043-0342 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 醫(yī)學(xué) | 生物工程與應(yīng)用微生物 | 1.767 | N/A | 0393-6155 |
JOURNAL OF ANTIBIOTICS | 醫(yī)學(xué) | 生物工程與應(yīng)用微生物 | 2.446 | N/A | 0021-8820 |
發(fā)現(xiàn)心儀選題請(qǐng)?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊